Proteasome subunits mRNA expressions correlate with male BMI: Implications for a role in obesity

Obesity

Volumn 17, Issue 5, 2009, Pages 1044-1049

  Sakamoto, Kozue ^a   Sato, Youichi ^a   Shinka, Toshikatsu ^a   Sei, Masako ^a   Nomura, Isoko ^a   Umeno, Mayumi ^a   Ewis, Ashraf A ^a   Nakahori, Yutaka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PRIMER DNA; PROTEASOME; PROTEIN SUBUNIT;

ARTICLE; BLOOD; BODY MASS; CELL LINE; EPSTEIN BARR VIRUS; FEMALE; GENETICS; HUMAN; MALE; MASS SPECTROMETRY; OBESITY; POLYMERASE CHAIN REACTION; REFERENCE VALUE;

BODY MASS INDEX; CELL LINE; DNA PRIMERS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; OBESITY; POLYMERASE CHAIN REACTION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; REFERENCE VALUES; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

HUMAN HERPESVIRUS 4;

EID: 67349249156     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.612     Document Type: Article

References (40)

1. Lew EA, Garfinkel L. Variation in mortality by weight among 750,000 men and women. J Chronic Dis 1979;32:563-576.
2. Larsson B, Björntorp R Tibblin G. The health consequences of moderate obesity. Int J Obes 1981 ;5:97-116.
3. Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of U.S. adults. Am J Epidemiol 1997;146:214-222.
4. Tchernof A, Lamarche B, Prud'Homme D et al. The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 1996;19:629-637.
5. Dyer AR, Elliott P. The INTERSALT study: relations of body mass index to blood pressure. INTERSALT Co-operative Research Group. J Hum Hypertens 1989;3:299-308.
6. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-977.
7. Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004;116:337-350.
8. Friendman JM. Obesity in the new millennium. Nature 2000;404:632-634.
9. Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
10. Montague CT, Farooqi IS, Whitehead JP et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-908.
11. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213-215.
12. Clement K, Vaisse C, Lahlou N et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
13. Boss O, Hagen T Lowell BB. Uncoupling protein 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes 2000;49:143-156.
14. Fleury C, Neverova M, Collins, Set al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997;15:223-224.
15. Nakano T, Shinka T, Sci M et al. A/G heterozygote of the A-3826G polymorphism in the UCP-1 gene has higher BMI than A/A and G/G homozygote in young Japanese males. J Med Invest 2006;53:218-222.
16. Walston J, Silver K, Bogardus C et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995;333:343-347.
17. Kadowaki H, Yasuda K, Iwamoto K et al. A mutation in the β-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese Subjects. Biochem Biophys Res Commun 1995;212:555-560.
18. Kim-Motoyama H, Yasuda K, Yamaguchi T et al. A mutation of the beta 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 1997;40:469-472.
19. Mori Y, Kim-Motoyama H, Ito Y et al. The Gln27Glu beta2 adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun 1999;258:138-140.
20. Kubota N, Terauchi Y, Miki H et al. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999;4:597-600.
21. Chan MA, Stein LD, Dosch HM, Sigal NH. Heterogeneity of EBV-transformable human B lymphocyte populations. J Immunol 1986;136: 106-112.
22. Miller G, Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 1973;70:190-194.
23. Tanaka K, Tsurumi C. The 26S proteasome: subunits and functions. Mol Biol Rep 1997;24:3-11.
24. Wolf DH, Hilt W. The proteasome: a proteolytic nanomachine of cell regulation and waste disposal. Biochim Biophys Acta 2004;1695:19-31.
25. Ma CR Slaughter CA, deMartino GN. Identification, purification, and characterization of a protein activator (PA28) of the 20S proteasome (macropain). J Biol Chem 1992;267:10515-10523.
26. Dubiel W, Pratt G, Ferrell K, Rechsteiner M. Purification of an 11S regulator of the multicatalytic proteasome. J Biol Chem 1992;267:22369-22377.
27. Kennedy S. Proteomics profiling from human samples: the body fluid alternative. Toxicol Lett 2001 ;120:379-384.
28. Baussant T, Bougueleret L, Johnson A et al. Effective depletion of albumin using a new peptide-base affinity medium. Proteomics 2005;4:973-977.
29. Ishibashi E, Eguchi Y, Eguchi T et al. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females. J Gastroenterol Hepatol 2008;23: 908-913.
30. Liu J, Farmer SR. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a adipogenic genes. J Biol Chem 2004;279:45020-45027.
31. King RW, Deshaies RJ, Peters JM, Kirschner MW. How proteolysis drives the cell cycle. Science 1996;274:1652-1659.
32. Orlowski RZ. The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 1999;6:303-313.
33. Oikawa T, Sasaki T Nakamura M et al. The proteasome is involved in angiogenesis. Biochem Biophys Res Commun 1998;246:243-248.
34. Read MA, Neish AS, Luscinskas FW et al. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995;2:493-506.
35. Desterro JM, Rodriguez MS, Hay RT Regulation of transcription factors by protein degradation. Cell Mol Life Sci 2000;57:1207-1219.
36. Nisoli E, Briscini L, Tonello C, De Giuli-Morghen C, Carruba MO. Tumor necrosis factor-alpha induces apoptosis in rat brown adipocytes. Cell Death Differ 1997;4:771-778.
37. Parras A, Alvarez AM, Valladares A, Benito M. TNF-alpha induces apoptosis in rat fetal brown adipocytes in primary culture. FEBS Lett 1997;416:324-328.
38. Prins JB, Niesler CU, Winterford CM et al. Tumor necrosis factor-alpha induces apoptosis of human adipose cells. Diabetes 1997;46: 1939-1944.
39. Marfella R, D'Amico M, Di Filippo C et al. The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes. Cardiovasc Diabetol 2007;6:35.
40. Pallarés-Trujillo J, Carbó N, López-Soriano FJ, Argilés JM. Does the mechanism responsible for TNF-mediated insulin resistance involve the proteasome? Med Hypotheses 2000;54:565-569.